Monday, August 30, 2010

Former Onyx boss Renton joins Affymax board - St. Louis Business Journal:

http://as1web.com/?page_id=196
Hematide is in a Phase III trial. Renton led Onyx for nearl 15 years, stepping down in Februarhy 2008as president, CEO, chairmanj and a member of Onyx’s board. At the company, he helpeed negotiate a research, developmentt and commercialization partnership with that resulted inthe anti-cancere drug Nexavar. Nexavar tablets, which cost about $5,000 a mont in the United States and areapproachinv $1 billion in annual sales, are approved in more than 80 countried to treat kidney cancet and 70-plus countries for liver Prior to joining Onyx, Renton was presidentt and COO of Chiron, which acquired Cetua in 1991.
Renton had been presidentg of Cetussince 1990, COO sincew 1987 and CFO from 1983 to 1987. Rentob also serves on the boardsof , Cepheidr and the Special Olympics of Northern

No comments:

Post a Comment